Prostate tumors progress from AR+ adenocarcinomas to AR- therapy-induced NEPC via an extensive network of transcriptional reprogramming events that lead to the expression and maintenance of neuronal features [36]. The gene discussed is AR; the disease is prostate neoplasm.